Merck KGaA’s lung cancer drugs show promise in early-stage trials
FRANKFURT (Reuters) – Germany’s Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping efforts to find drug-industry partners…